what is glp 1/gip The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review GLP-1 Agonists Can Be Heaven

Wondering what happens when you stop taking GLP-1 medications for weight loss

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

Methods We obtained the data from PubMed, Scopus, Embase, and Web of Science for all eligible studies, including clinical trials (RCT) and cohorts comparing GLP-1 RAs to placebo or other hypoglycemic agents in patients with HFpEF published until December 31st, 2024

Quick Links If you are a dietitian working in client nutrition counseling, chances are youve had at least one client mention GLP-1 medications in the past few months